BENZETHONIUM CHLORIDE

BENZETHONIUM CHLORIDE was reported 129 times

BENZETHONIUM CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE HYPERTROPHY 1 0.0714
1 MEDIASTINAL CYST 1 0.0556
2 GALLBLADDER ADENOCARCINOMA 3 0.0423
3 HER2 POSITIVE GASTRIC CANCER 1 0.0312
4 ACTIVATED PROTEIN C RESISTANCE 1 0.0303
5 ACANTHAMOEBA KERATITIS 1 0.0270
6 GIANT PAPILLARY CONJUNCTIVITIS 1 0.0200
7 TISSUE DISCOLOURATION 1 0.0175
8 FOREIGN BODY IN SKIN OR SUBCUTANEOUS TISSUE 1 0.0145
9 BONE MARROW LEUKAEMIC CELL INFILTRATION 1 0.0122
10 PRIMARY EFFUSION LYMPHOMA 1 0.0116
11 PERICORONITIS 1 0.0110
12 PSEUDOCHOLELITHIASIS 1 0.0093
13 PROPIONIBACTERIUM INFECTION 1 0.0093
14 APPLICATION SITE NODULE 1 0.0073
15 LIMB FRACTURE 1 0.0067
16 APPLICATION SITE WOUND 1 0.0061
17 TANGENTIALITY 1 0.0052
18 XANTHOMA 1 0.0050
19 VOCAL CORD PARESIS 1 0.0043
20 INFECTIVE SPONDYLITIS 1 0.0041
21 ANTICOAGULANT THERAPY 1 0.0035
22 BLADDER TAMPONADE 1 0.0033
23 CONTRAINDICATED DEVICE USED 1 0.0031
24 TINEA VERSICOLOUR 1 0.0028
25 INFECTED DERMAL CYST 1 0.0028
26 PORTAL VENOUS GAS 1 0.0028
27 SYPHILIS 2 0.0028
28 BOVINE TUBERCULOSIS 1 0.0026
29 TISSUE INJURY 1 0.0023
30 SEXUAL ABUSE 1 0.0023
31 ECZEMA ASTEATOTIC 1 0.0021
32 STATUS ASTHMATICUS 1 0.0021
33 GRAFT VERSUS HOST DISEASE IN LUNG 1 0.0021
34 DRAINAGE 1 0.0020
35 WATER INTOXICATION 1 0.0020
36 APPLICATION SITE INFECTION 1 0.0020
37 EYE INFECTION BACTERIAL 1 0.0018
38 NAIL DYSTROPHY 1 0.0018
39 CORNEAL EPITHELIUM DEFECT 1 0.0017
40 PAROTID GLAND ENLARGEMENT 1 0.0015
41 PELVIC FLUID COLLECTION 1 0.0014
42 LIP EROSION 1 0.0014
43 REFLUX OESOPHAGITIS 1 0.0013
44 HERPES ZOSTER DISSEMINATED 1 0.0012
45 BARRETT'S OESOPHAGUS 1 0.0012
46 ABDOMINAL SYMPTOM 1 0.0012
47 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
48 HILAR LYMPHADENOPATHY 1 0.0011
49 ADENOCARCINOMA OF COLON 2 0.0011
50 NEUROENDOCRINE CARCINOMA OF THE SKIN 1 0.0010
51 MUCOSAL DISORDER 1 0.0010
52 REDUCED FACIAL EXPRESSION 1 0.0010
53 NON-CARDIOGENIC PULMONARY OEDEMA 1 0.0009
54 CARDIAC HYPERTROPHY 1 0.0009
55 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
56 APPLICATION SITE DISCHARGE 1 0.0009
57 ISCHAEMIC CEREBRAL INFARCTION 1 0.0009
58 PULMONARY INFARCTION 2 0.0008
59 PHARYNGEAL INFLAMMATION 1 0.0008
60 APPLICATION SITE SCAR 1 0.0008
61 IMMUNE RECONSTITUTION SYNDROME 1 0.0008
62 TUMOUR PAIN 1 0.0008
63 NAIL INFECTION 1 0.0007
64 NOROVIRUS INFECTION 1 0.0007
65 SEBORRHOEIC KERATOSIS 1 0.0007
66 PNEUMONIA PNEUMOCOCCAL 1 0.0007
67 SMALL CELL LUNG CANCER 1 0.0007
68 INFECTIOUS PLEURAL EFFUSION 1 0.0007
69 VASCULAR RUPTURE 1 0.0006
70 SYSTEMIC INFECTION 1 0.0006
71 SALMONELLOSIS 1 0.0006
72 ENTERITIS INFECTIOUS 1 0.0006
73 WOUND COMPLICATION 2 0.0006
74 LIVER TRANSPLANT REJECTION 1 0.0006
75 LOBAR PNEUMONIA 1 0.0005
76 PSYCHIATRIC DECOMPENSATION 1 0.0005
77 OESOPHAGEAL CANDIDIASIS 2 0.0005
78 HYPOPHYSITIS 1 0.0005
79 RENAL HAEMORRHAGE 1 0.0005
80 VENOUS THROMBOSIS LIMB 1 0.0005
81 SKIN INDURATION 1 0.0005
82 LUNG ABSCESS 1 0.0005
83 PERIODONTITIS 1 0.0005
84 CERVICAL DYSPLASIA 1 0.0005
85 REACTION TO EXCIPIENT 1 0.0004
86 LYMPHADENITIS 1 0.0004
87 METASTASES TO PERITONEUM 1 0.0004
88 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
89 LUNG OPACITY 1 0.0004
90 ALCOHOL POISONING 1 0.0004
91 SHOCK HAEMORRHAGIC 3 0.0004
92 GASTRIC ULCER HAEMORRHAGE 2 0.0004
93 PROCTITIS 1 0.0004
94 HYPERTONIC BLADDER 1 0.0003
95 HISTIOCYTOSIS HAEMATOPHAGIC 1 0.0003
96 CONTRAINDICATED PRODUCT ADMINISTERED 10 0.0003
97 KERATITIS 1 0.0003
98 MEDICAL DEVICE DISCOMFORT 1 0.0003
99 PNEUMONIA VIRAL 1 0.0003
100 ORAL CANDIDIASIS 4 0.0003
101 POTENTIATING DRUG INTERACTION 1 0.0003
102 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
103 SKIN WEEPING 1 0.0003
104 APPLICATION SITE PAIN 6 0.0003
105 DUODENAL ULCER PERFORATION 2 0.0003
106 LEUKOENCEPHALOPATHY 1 0.0003
107 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
108 HYPOALBUMINAEMIA 2 0.0003
109 PROCEDURAL HAEMORRHAGE 1 0.0003
110 AZOTAEMIA 1 0.0003
111 CYSTITIS HAEMORRHAGIC 1 0.0002
112 HYPERURICAEMIA 1 0.0002
113 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
114 NEPHROGENIC ANAEMIA 1 0.0002
115 NON-SMALL CELL LUNG CANCER 1 0.0002
116 KIDNEY TRANSPLANT REJECTION 1 0.0002
117 HUMERUS FRACTURE 1 0.0002
118 INCORRECT DOSAGE ADMINISTERED 1 0.0002
119 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
120 APPLICATION SITE SWELLING 1 0.0002
121 DYSLIPIDAEMIA 1 0.0002
122 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0002
123 SERUM FERRITIN INCREASED 1 0.0002
124 ANAL ABSCESS 1 0.0002
125 GINGIVITIS 1 0.0002
126 HIP SURGERY 1 0.0002
127 NONSPECIFIC REACTION 1 0.0002
128 ENTEROCOLITIS 1 0.0002
129 METASTASES TO LIVER 3 0.0002
130 BRADYKINESIA 1 0.0002
131 PLEURISY 1 0.0002
132 TYPE 1 DIABETES MELLITUS 1 0.0002
133 VULVOVAGINAL BURNING SENSATION 1 0.0002
134 APPLICATION SITE IRRITATION 2 0.0002
135 PROCTALGIA 1 0.0002
136 UVEITIS 2 0.0001
137 ENCEPHALITIS 1 0.0001
138 PULMONARY TOXICITY 1 0.0001
139 HAND FRACTURE 1 0.0001
140 GRAFT VERSUS HOST DISEASE 1 0.0001
141 FAECES SOFT 1 0.0001
142 GASTROENTERITIS 2 0.0001
143 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
144 HAEMOLYSIS 1 0.0001
145 ACUTE MYELOID LEUKAEMIA 2 0.0001
146 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
147 RHINITIS 1 0.0001
148 HAEMODIALYSIS 1 0.0001
149 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
150 APPLICATION SITE ERYTHEMA 3 0.0001
151 DRUG ERUPTION 2 0.0001
152 OSTEOMYELITIS 2 0.0001
153 HYPERSENSITIVITY 20 0.0001
154 HEPATIC ENCEPHALOPATHY 1 0.0001
155 ARTERIOSCLEROSIS 1 0.0001
156 HYPERCHOLESTEROLAEMIA 1 0.0001
157 THROMBOTIC MICROANGIOPATHY 1 0.0001
158 KNEE OPERATION 1 0.0001
159 OVARIAN CYST 1 0.0001
160 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
161 TOXIC SKIN ERUPTION 1 0.0001
162 VAGINAL DISCHARGE 1 0.0001
163 EYE DISCHARGE 1 0.0001
164 FOLLICULITIS 1 0.0001
165 SKIN LACERATION 1 0.0001
166 WOUND INFECTION 1 0.0001
167 DENTAL CARIES 1 0.0001
168 MALNUTRITION 1 0.0001
169 DERMATITIS CONTACT 1 0.0001
170 BACTERAEMIA 1 0.0001
171 MUSCLE RIGIDITY 1 0.0001
172 CYTOPENIA 1 0.0001
173 OSTEONECROSIS OF JAW 2 0.0001
174 GENERALISED OEDEMA 1 0.0001
175 PHARYNGITIS 1 0.0001
176 HEPATIC FUNCTION ABNORMAL 3 0.0001
177 PNEUMONIA ASPIRATION 2 0.0001
178 DYSMENORRHOEA 1 0.0001
179 EYE HAEMORRHAGE 1 0.0001
180 LUNG NEOPLASM MALIGNANT 3 0.0001
181 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
182 LYMPHOPENIA 1 0.0001
183 CARDIOGENIC SHOCK 1 0.0001
184 SKIN DISCOLOURATION 3 0.0001
185 TENDONITIS 1 0.0001
186 PNEUMOTHORAX 1 0.0001
187 ABSCESS 1 0.0001
188 INTERSTITIAL LUNG DISEASE 3 0.0001
189 METASTASES TO BONE 1 0.0001
190 FACE OEDEMA 1 0.0001
191 METRORRHAGIA 1 0.0001
192 SCAR 1 0.0001
193 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
194 HEPATIC STEATOSIS 1 0.0001
195 BACTERIAL INFECTION 1 0.0001
196 FOOT FRACTURE 1 0.0001
197 GASTRIC ULCER 1 0.0001
198 PROTEINURIA 1 0.0001
199 HAEMORRHOIDS 1 0.0001
200 MENORRHAGIA 1 0.0001
201 PRESCRIBED UNDERDOSE 1 0.0001
202 CYTOKINE RELEASE SYNDROME 1 0.0000
203 FULL BLOOD COUNT DECREASED 1 0.0000
204 PRODUCT ADMINISTRATION ERROR 1 0.0000
205 STOMATITIS 3 0.0000
206 PLEURAL EFFUSION 3 0.0000
207 BONE MARROW FAILURE 1 0.0000
208 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
209 PULMONARY HYPERTENSION 1 0.0000
210 IRRITABLE BOWEL SYNDROME 1 0.0000
211 SKIN CANCER 1 0.0000
212 PRURITUS GENERALISED 1 0.0000
213 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
214 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
215 TOOTH DISORDER 1 0.0000
216 RASH MACULO-PAPULAR 1 0.0000
217 COLITIS ULCERATIVE 2 0.0000
218 PERICARDIAL EFFUSION 1 0.0000
219 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
220 OCULAR HYPERAEMIA 2 0.0000
221 DISEASE RECURRENCE 2 0.0000
222 PRODUCT COMPLAINT 1 0.0000
223 HYPOPHAGIA 1 0.0000
224 EXPOSURE VIA SKIN CONTACT 1 0.0000
225 MUCOSAL INFLAMMATION 1 0.0000
226 TREATMENT FAILURE 3 0.0000
227 RHEUMATOID ARTHRITIS 4 0.0000
228 EYE IRRITATION 2 0.0000
229 PSYCHOTIC DISORDER 1 0.0000
230 OESOPHAGEAL CARCINOMA 1 0.0000
231 LACRIMATION INCREASED 1 0.0000
232 DRUG-INDUCED LIVER INJURY 1 0.0000
233 OSTEONECROSIS 1 0.0000
234 NAUSEA 24 0.0000
235 STAPHYLOCOCCAL INFECTION 1 0.0000
236 HEADACHE 19 0.0000
237 FEBRILE NEUTROPENIA 2 0.0000
238 EYE PRURITUS 1 0.0000
239 TYPE 2 DIABETES MELLITUS 1 0.0000
240 SINUSITIS 3 0.0000
241 BURNING SENSATION 2 0.0000
242 HYPERKALAEMIA 1 0.0000
243 PRODUCT ADHESION ISSUE 1 0.0000
244 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
245 C-REACTIVE PROTEIN INCREASED 1 0.0000
246 COLITIS 1 0.0000
247 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
248 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
249 ABNORMAL BEHAVIOUR 1 0.0000
250 DYSKINESIA 1 0.0000
251 BLINDNESS 1 0.0000
252 NEUTROPHIL COUNT DECREASED 1 0.0000
253 CARDIO-RESPIRATORY ARREST 1 0.0000
254 ROAD TRAFFIC ACCIDENT 1 0.0000
255 RENAL IMPAIRMENT 2 0.0000
256 HYPERTENSION 5 0.0000
257 RENAL FAILURE 3 0.0000
258 LIVER DISORDER 1 0.0000
259 THROAT IRRITATION 1 0.0000
260 HYPOKALAEMIA 1 0.0000
261 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
262 RENAL DISORDER 1 0.0000
263 SWELLING 2 0.0000
264 PULMONARY EMBOLISM 2 0.0000
265 LEUKOPENIA 1 0.0000
266 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
267 ECZEMA 1 0.0000
268 DRUG EFFECT DECREASED 1 0.0000
269 PNEUMONIA 6 0.0000
270 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
271 TREATMENT NONCOMPLIANCE 1 0.0000
272 ANAPHYLACTIC REACTION 1 0.0000
273 SEPSIS 2 0.0000
274 PANCYTOPENIA 1 0.0000
275 BLISTER 1 0.0000
276 EYE PAIN 1 0.0000
277 HERPES ZOSTER 1 0.0000
278 PYREXIA 6 0.0000
279 ABDOMINAL PAIN 4 0.0000
280 COVID-19 3 0.0000
281 SURGERY 1 0.0000
282 BLADDER CANCER 1 0.0000
283 CATARACT 1 0.0000
284 FEELING HOT 1 0.0000
285 ANAEMIA 3 0.0000
286 RHINORRHOEA 1 0.0000
287 DEVICE EXPULSION 1 0.0000
288 DEEP VEIN THROMBOSIS 1 0.0000
289 BLOOD CREATININE INCREASED 1 0.0000
290 INFUSION RELATED REACTION 1 0.0000
291 BLOOD PRESSURE DECREASED 1 0.0000
292 WEIGHT DECREASED 4 0.0000
293 UNDERDOSE 1 0.0000
294 BRONCHITIS 1 0.0000
295 HALLUCINATION 1 0.0000
296 HOT FLUSH 1 0.0000
297 DIABETES MELLITUS 1 0.0000
298 DECREASED APPETITE 3 0.0000
299 ARTHRITIS 1 0.0000
300 CARDIAC FAILURE 1 0.0000
301 PROSTATE CANCER 1 0.0000
302 TREMOR 2 0.0000
303 FALL 4 0.0000
304 URINARY TRACT INFECTION 2 0.0000
305 INTENTIONAL PRODUCT MISUSE 1 0.0000
306 GASTROINTESTINAL DISORDER 1 0.0000
307 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
308 DIARRHOEA 7 0.0000
309 NEUROPATHY PERIPHERAL 1 0.0000
310 GAIT DISTURBANCE 2 0.0000
311 CONTUSION 1 0.0000
312 DIZZINESS 5 0.0000
313 CHEST DISCOMFORT 1 0.0000
314 ERYTHEMA 2 0.0000
315 OVERDOSE 2 0.0000
316 CONSTIPATION 2 0.0000
317 ASTHMA 1 0.0000
318 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
319 BACK PAIN 2 0.0000
320 CHILLS 1 0.0000
321 JOINT SWELLING 1 0.0000
322 OEDEMA PERIPHERAL 1 0.0000
323 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
324 VISUAL IMPAIRMENT 1 0.0000
325 PSORIASIS 1 0.0000
326 INSOMNIA 2 0.0000
327 DEHYDRATION 1 0.0000
328 DRY SKIN 1 0.0000
329 PRODUCT QUALITY ISSUE 1 0.0000
330 NEUTROPENIA 1 0.0000
331 MEMORY IMPAIRMENT 1 0.0000
332 ARTHRALGIA 3 0.0000
333 COUGH 2 0.0000
334 DEATH 6 0.0000
335 OFF LABEL USE 6 0.0000
336 HYPOAESTHESIA 1 0.0000
337 CONDITION AGGRAVATED 2 0.0000
338 PAIN 4 0.0000
339 HOSPITALISATION 1 0.0000
340 VOMITING 3 0.0000
341 DRUG INTERACTION 1 0.0000
342 CONFUSIONAL STATE 1 0.0000
343 ABDOMINAL DISCOMFORT 1 0.0000
344 NASOPHARYNGITIS 1 0.0000
345 CHEST PAIN 1 0.0000
346 ASTHENIA 2 0.0000
347 DRUG INEFFECTIVE 7 0.0000
348 DYSPNOEA 3 0.0000
349 PRURITUS 2 0.0000
350 HYPOTENSION 1 0.0000
351 SOMNOLENCE 1 0.0000
352 ABDOMINAL PAIN UPPER 1 0.0000
353 RASH 2 0.0000
354 DEPRESSION 1 0.0000
355 FEELING ABNORMAL 1 0.0000
356 FATIGUE 3 0.0000